Aakanksha Angra: Building a Community for Advances in ALL
Aakanksha Angra, Senior Manager, Learning Scientist at American Society of Hematology, shared ASH’s post on LinkedIn:
”The Acute Lymphoblastic Leukemia (ALL) landscape is complex and constantly evolving.
For community clinicians without built-in resources, keeping up can feel isolating.
ALL ASH Connections was built to change that- live QAs, discussion boards, and a peer community that helps you stay informed and connected.
Our first interactive case on MRD-Guided Escalation in Pediatric B-ALL goes live May 18, 2026 at 12 PM, EST.
Our first virtual live Q&A hosted by Drs. Rabi Hanna and Jennifer McNeer will be on June 2nd from 10-11 AM, EST.”
ASH Education shared a post on LinkedIn:
”Calling all healthcare providers!
The American Society of Hematology invites you to join the ALL (Acute Lymphoblastic Leukemia) community on ASH Connections, a disease-focused space where you can engage with case-based scenarios, join discussion boards, and participate in live QA sessions with experts. No ASH membership required.
Spread the word!
Visit to join the ALL Community today!”
Stay updated with Hemostasis Today.
-
May 9, 2026, 22:55Romiplostim Versus Placebo in the Management of Chemotherapy-Induced Thrombocytopenia – Transfusion Evidence Library
-
May 9, 2026, 22:43Simon Ash: Gestational Thrombocytopenia and Maternal Risk at SOAPAM 2026
-
May 9, 2026, 22:18Rupam Manna: Thrombocytopenia in Oncology – Complete High-Yield Guide for Safe Chemotherapy Delivery
-
May 9, 2026, 22:12Muhammad Aasim Ali: Treatment Strategies for Chemotherapy-Induced Cytopenias
-
May 9, 2026, 16:38Joseph R. Shaw: Risk Stratification is Only Useful if It is Practical, Consistent, and Easy to Apply at the Bedside
-
May 9, 2026, 16:11Milad Abdalla: When 180,000 Becomes 45,000 – The EDTA Trap
-
May 9, 2026, 16:10Gertrud U. Rey: Describing the Mechanism That Causes VITT
-
May 9, 2026, 16:09Dima Shulkin: The Earliest Warning Sign of a Severe Heart Attack May Already Be in the CBC
-
May 9, 2026, 16:08Luisanna M. Sánchez: Selected for the ASH Clinical Research Training Institute